CNSP · CIK 0001729427 · operating
CNS Pharmaceuticals, Inc. (CNSP) is a pharmaceutical preparations company incorporated in NV, listed on the Nasdaq. With a market capitalization of $2 million, CNS Pharmaceuticals, Inc. is a micro-cap company. The stock currently trades at $3.02, down 5.27% today, with a 52-week range of $2.95–$55.20. The company trades at a trailing P/E of 0.0x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-38.87 | $-38.87 | -677.4% | |
| 2023 | $-5.00 | $-5.00 | +55.4% | |
| 2022 | $-11.22 | $-11.22 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0001683168-25-002139 | SEC ↗ |
| 2023-12-31 | 2024-04-01 | 0001683168-24-002032 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001683168-23-002086 | SEC ↗ |
| 2021-12-31 | 2022-03-03 | 0001683168-22-001401 | SEC ↗ |
| 2020-12-31 | 2021-02-12 | 0001683168-21-000533 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001683168-20-000781 | SEC ↗ |